SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ashley T. Evans, Keith R. Loeb, Howard M. Shulman, Sajida Hassan, Wan Chong Qiu, David M. Hockenbery, George N. Ioannou, Thomas R. Chauncey, David R. Gretch, George B. McDonald, Fibrosing Cholestatic Hepatitis C After Hematopoietic Cell Transplantation, The American Journal of Surgical Pathology, 2015, 39, 2, 212

    CrossRef

  2. 2
    Harrys A. Torres, Pearlie P. Chong, Marcos De Lima, Mark S. Friedman, Sergio Giralt, Sarah P. Hammond, Patrick J. Kiel, Henry Masur, George B. McDonald, John R. Wingard, Maya Gambarin-Gelwan, Hepatitis C Virus Infection among Hematopoietic Cell Transplant Donors and Recipients: American Society for Blood and Marrow Transplantation Task Force Recommendations, Biology of Blood and Marrow Transplantation, 2015,

    CrossRef

  3. 3
    J.P. Norvell, Liver disease after hematopoietic cell transplantation in adults, Transplantation Reviews, 2015, 29, 1, 8

    CrossRef

  4. 4
    Pankaj Puri, Anil C. Anand, Vivek A. Saraswat, Subrat K. Acharya, Shiv K. Sarin, Radha K. Dhiman, Rakesh Aggarwal, Shivaram P. Singh, Deepak Amarapurkar, Anil Arora, Mohinish Chhabra, Kamal Chetri, Gourdas Choudhuri, Vinod K. Dixit, Ajay Duseja, Ajay K. Jain, Dharmesh Kapoor, Premashis Kar, Abraham Koshy, Ashish Kumar, Kaushal Madan, Sri P. Misra, Mohan V.G. Prasad, Aabha Nagral, Amarendra S. Puri, R. Jeyamani, Sanjiv Saigal, Samir Shah, Praveen K. Sharma, Ajit Sood, Sandeep Thareja, Manav Wadhawan, Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India, Journal of Clinical and Experimental Hepatology, 2014, 4, 2, 117

    CrossRef

  5. 5
    H.-H. Hsiao, Y.-C. Liu, H.-C. Wang, C.-H. Wu, S.-F. Cho, J.-F. Hsu, H.-J. Tsai, S.Y. Hsiao, C.-S. Chang, S.-F. Lin, T.-C. Liu, W.-L. Chuang, M.-L. Yu, Hepatitis C transmission from viremic donors in hematopoietic stem cell transplant, Transplant Infectious Disease, 2014, 16, 6
  6. 6
    N. Chao, How I treat sinusoidal obstruction syndrome, Blood, 2014, 123, 26, 4023

    CrossRef

  7. 7
    Can-Lan Sun, John H. Kersey, Liton Francisco, Saro H. Armenian, K. Scott Baker, Daniel J. Weisdorf, Stephen J. Forman, Smita Bhatia, Burden of Morbidity in 10+ Year Survivors of Hematopoietic Cell Transplantation: Report from the Bone Marrow Transplantation Survivor Study, Biology of Blood and Marrow Transplantation, 2013, 19, 7, 1073

    CrossRef

  8. 8
    Hideki Nakasone, Saiko Kurosawa, Kimikazu Yakushijin, Shuichi Taniguchi, Makoto Murata, Kazuhiro Ikegame, Takeshi Kobayashi, Tetsuya Eto, Koichi Miyamura, Hisashi Sakamaki, Yasuo Morishima, Tokiko Nagamura, Ritsuro Suzuki, Takahiro Fukuda, Impact of hepatitis C virus infection on clinical outcome in recipients after allogeneic hematopoietic cell transplantation, American Journal of Hematology, 2013, 88, 6
  9. 9
    Ayad Ahmed Hussein, Abdulhadi Al-Zaben, Lubna Ghatasheh, Abeer Natsheh, Tuka Hammada, Fawzi Abdel-Rahman, Husam Abu-Jazar, Shanta Sharma, Rula Najjar, Haydar Frangoul, Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major, Pediatric Blood & Cancer, 2013, 60, 8
  10. 10
    Laurie D. DeLeve, Drug-induced Liver Disease, 2013,

    CrossRef

  11. 11
    Selim Corbacioglu, Nancy Kernan, Leslie Lehmann, Joel Brochstein, Carolyn Revta, Stephan Grupp, Paul Martin, Paul G Richardson, Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation, Expert Review of Hematology, 2012, 5, 3, 291

    CrossRef

  12. 12
    Aiko Kida, George B. McDonald, Gastrointestinal, Hepatobiliary, Pancreatic, and Iron-Related Diseases in Long-Term Survivors of Allogeneic Hematopoietic Cell Transplantation, Seminars in Hematology, 2012, 49, 1, 43

    CrossRef

  13. 13
    P Ljungman, A Locasciulli, V G de Soria, A N Békássy, L Brinch, I Espigado, A Ferrant, I M Franklin, J O'Riordan, M Rovira, P Shaw, H Einsele, Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy, Bone Marrow Transplantation, 2012, 47, 9, 1217

    CrossRef

  14. 14
    Eolia Brissot, Bipin N. Savani, Mohamad Mohty, Management of High Ferritin in Long-Term Survivors After Hematopoietic Stem Cell Transplantation, Seminars in Hematology, 2012, 49, 1, 35

    CrossRef

  15. 15
    M. Tomblyn, M. Chen, M. Kukreja, M.D. Aljurf, F. Al Mohareb, B.J. Bolwell, J.-Y. Cahn, M.H. Carabasi, R.P. Gale, R.E. Gress, V. Gupta, G.A. Hale, P. Ljungman, R.T. Maziarz, J. Storek, J.R. Wingard, J.-A.H. Young, M.M. Horowitz, K.K. Ballen, No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantation, Transplant Infectious Disease, 2012, 14, 5
  16. 16
    Lauri M. Burroughs, Ann E. Woolfrey, Barry E. Storer, H. Joachim Deeg, Mary E. D. Flowers, Paul J. Martin, Paul A. Carpenter, Kris Doney, Frederick R. Appelbaum, Jean E. Sanders, Rainer Storb, Success of allogeneic marrow transplantation for children with severe aplastic anaemia, British Journal of Haematology, 2012, 158, 1
  17. 17
    Stefan G. Hübscher, Andrew D. Clouston, MacSween's Pathology of the Liver, 2012,

    CrossRef

  18. 18
    Michael L. Nieder, George B. McDonald, Aiko Kida, Sangeeta Hingorani, Saro H. Armenian, Kenneth R. Cooke, Michael A. Pulsipher, K. Scott Baker, National Cancer Institute–National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on Late Effects After Pediatric Hematopoietic Cell Transplantation: Long-Term Organ Damage and Dysfunction, Biology of Blood and Marrow Transplantation, 2011, 17, 11, 1573

    CrossRef

  19. 19
    Mylène Sebagh, Daniel Azoulay, Bruno Roche, Emir Hoti, Vincent Karam, Elina Teicher, Laurence Bonhomme-Faivre, Faouzi Saliba, Jean-Charles Duclos-Vallée, Didier Samuel, Significance of isolated hepatic veno-occlusive disease/sinusoidal obstruction syndrome after liver transplantation, Liver Transplantation, 2011, 17, 7
  20. 20
    George B. McDonald, Hepatobiliary Complications of Hematopoietic Cell Transplantation, 40 Years On, Hepatology, 2010, 51, 4
  21. 21
    Y R Abou-Mourad, B C Lau, M J Barnett, D L Forrest, D E Hogge, S H Nantel, T J Nevill, J D Shepherd, C A Smith, K W Song, H J Sutherland, C L Toze, J C Lavoie, Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens, Bone Marrow Transplantation, 2010, 45, 2, 295

    CrossRef

  22. 22
    Anne M. Larson, George B. McDonald, Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 2010,

    CrossRef

  23. 23
    Marcie Tomblyn, Tom Chiller, Hermann Einsele, Ronald Gress, Kent Sepkowitz, Jan Storek, John R. Wingard, Jo-Anne H. Young, Michael A. Boeckh, Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective, Biology of Blood and Marrow Transplantation, 2009, 15, 10, 1143

    CrossRef

  24. 24
    References, Bone Marrow Transplantation, 2009, 44, 8, 537

    CrossRef

  25. 25
    M Sakai, S I Strasser, H M Shulman, S J McDonald, H G Schoch, G B McDonald, Severe hepatocellular injury after hematopoietic cell transplant: incidence, etiology and outcome, Bone Marrow Transplantation, 2009, 44, 7, 441

    CrossRef

  26. 26
    Laurie D. DeLeve, Dominique-Charles Valla, Guadalupe Garcia-Tsao, Vascular disorders of the liver, Hepatology, 2009, 49, 5
  27. 27
    Régis Peffault de Latour, Patricia Ribaud, Marie Robin, Dominique Valla, Patrick Marcellin, Gérard Socié, Tarik Asselah, Allogeneic hematopoietic cell transplant in HCV-infected patients, Journal of Hepatology, 2008, 48, 6, 1008

    CrossRef

  28. 28
    M Faraci, G Dini, Assessing the risk of transplant-related complications and individually tailoring the HSCT procedure in children and adolescents—is it possible?, Bone Marrow Transplantation, 2008, 42, S90

    CrossRef

  29. 29
    H K Mahmoud, A M El-Haddad, O A Fahmy, M El-Emary, A Nassar, M Abdel-Mooti, A Sobhy, A Sultan, Hematopoietic stem cell transplantation in Egypt, Bone Marrow Transplantation, 2008, 42, S76

    CrossRef

  30. 30
    Dominique Larrey, Hépatotoxicité des anti-TNFα, Revue du Rhumatisme, 2008, 75, 12, 1208

    CrossRef

  31. 31
    D. Larrey, Hépatotoxicité des immunosuppresseurs. Conduite diagnostique, Gastroentérologie Clinique et Biologique, 2008, 32, 5, S194

    CrossRef

  32. 32
    Larrey Dominique, Liver toxicity of TNFα antagonists, Joint Bone Spine, 2008, 75, 6, 636

    CrossRef

  33. 33
    Roberto J. Firpi, David R. Nelson, Management of viral hepatitis in hematologic malignancies, Blood Reviews, 2008, 22, 3, 117

    CrossRef

  34. 34
    Josh Levitsky, Michael F. Sorrell, Hepatic complications of hematopoietic cell transplantation, Current Gastroenterology Reports, 2007, 9, 1, 60

    CrossRef

  35. 35
    Enric Carreras, Risk assessment in haematopoietic stem cell transplantation: The liver as a risk factor, Best Practice & Research Clinical Haematology, 2007, 20, 2, 231

    CrossRef

  36. 36
    George B. McDonald, Advances in prevention and treatment of hepatic disorders following hematopoietic cell transplantation, Best Practice & Research Clinical Haematology, 2006, 19, 2, 341

    CrossRef

  37. 37
    S. Matthes-Martin, D. Leithner, H. Gadner, Allogene Stammzelltransplantation bei Migranten mit nichtmalignen Krankheiten, Monatsschrift Kinderheilkunde, 2006, 154, 11, 1098

    CrossRef

  38. 38
    Howard M. Shulman, David Kleiner, Stephanie J. Lee, Thomas Morton, Steven Z. Pavletic, Evan Farmer, J. Margaret Moresi, Joel Greenson, Anne Janin, Paul J. Martin, George McDonald, Mary E.D. Flowers, Maria Turner, Jane Atkinson, Jay Lefkowitch, M. Kay Washington, Victor G. Prieto, Stella K. Kim, Zsolt Argenyi, A. Hafeez Diwan, Asif Rashid, Kim Hiatt, Dan Couriel, Kirk Schultz, Sharon Hymes, Georgia B. Vogelsang, Histopathologic Diagnosis of Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report, Biology of Blood and Marrow Transplantation, 2006, 12, 1, 31

    CrossRef

  39. 39
    G. B. McDONALD, Review article: management of hepatic disease following haematopoietic cell transplant, Alimentary Pharmacology & Therapeutics, 2006, 24, 3
  40. 40
    A. HELMY, Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome, Alimentary Pharmacology & Therapeutics, 2006, 23, 1
  41. 41
    Ted A. Gooley, Pankaj Rajvanshi, H. Gary Schoch, George B. McDonald, Serum bilirubin levels and mortality after myeloablative allogeneic hematopoietic cell transplantation, Hepatology, 2005, 41, 2
  42. 42
    R Peffault de Latour, T Asselah, V Lévy, C Scieux, A Devergie, P Ribaud, H Espérou, R Traineau, E Gluckman, D Valla, P Marcellin, G Socié, Treatment of chronic hepatitis C virus in allogeneic bone marrow transplant recipients, Bone Marrow Transplantation, 2005, 36, 8, 709

    CrossRef

  43. 43
    ELLEN BUTENSKY, ZAHRA PAKBAZ, DRUCILLA FOOTE, MARK C. WALTERS, ELLIOTT P. VICHINSKY, PAUL HARMATZ, Treatment of Hepatitis C Virus Infection in Thalassemia, Annals of the New York Academy of Sciences, 2005, 1054, 1
  44. 44
    Raúl J Andrade, Raquel Camargo, M Isabel Lucena, Rocío González-Grande, Causality assessment in drug-induced hepatotoxicity, Expert Opinion on Drug Safety, 2004, 3, 4, 329

    CrossRef

  45. 45
    G.C. MacQuillan, D. Mutimer, Fulminant liver failure due to severe veno-occlusive disease after haematopoietic cell transplantation: a depressing experience, QJM, 2004, 97, 9, 581

    CrossRef

  46. 46
    William M. Lee, Drug-Induced Hepatotoxicity, New England Journal of Medicine, 2003, 349, 5, 474

    CrossRef

  47. 47
    Shaji Kumar, Laurie D. Deleve, Patrick S. Kamath, Ayalew Tefferi, Hepatic Veno-occlusive Disease (Sinusoidal Obstruction Syndrome) After Hematopoietic Stem Cell Transplantation, Mayo Clinic Proceedings, 2003, 78, 5, 589

    CrossRef

  48. 48
    Anna Rita Gigliotti, Francesca Fioredda, Raffaella Giacchino, Hepatitis B and C Infection in Children Undergoing Chemotherapy or Bone Marrow Transplantation, Journal of Pediatric Hematology/Oncology, 2003, 25, 3, 184

    CrossRef

  49. 49
    Scott Keeley, John R. Lake, Hepatitis C in the setting of kidney, heart, lung, and bone marrow transplants, Current Hepatitis Reports, 2003, 2, 4, 159

    CrossRef

  50. 50
    Shing-Yan Ma, Wing-Yan Au, Irene O. L. Ng, Albert K. W. Lie, Anskar Y. H. Leung, Raymond H. S. Liang, George K. K. Lau, Yok-Lam Kwong, ROLE OF LIVER BIOPSY IN THE MANAGEMENT OF LIVER DYSFUNCTION AFTER HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN A HEPATITIS B VIRUS-PREVALENT PATIENT POPULATION1, Transplantation, 2003, 76, 1, 169

    CrossRef

  51. 51
    John T. H. T. Yu, George K. K. Lau, Treatment of hepatitis B and C following nonliver organ transplants, Current Hepatitis Reports, 2003, 2, 2, 82

    CrossRef

  52. 52
    George Lau, Simone Strasser, George McDonald, Management of Infection in Oncology Patients, 2003,

    CrossRef

  53. 53
    Sally Arai, Linda A. Lee, Georgia B. Vogelsang, A Systematic Approach to Hepatic Complications in Hematopoietic Stem Cell Transplantation, Journal of Hematotherapy & Stem Cell Research, 2002, 11, 2, 215

    CrossRef

  54. 54
    Vijayrama Poreddy, Laurie D DeLeve, Hepatic circulatory diseases associated with chronic myeloid disorders, Clinics in Liver Disease, 2002, 6, 4, 909

    CrossRef

  55. 55
    J.Mark Jackson, Hepatitis C and the skin, Dermatologic Clinics, 2002, 20, 3, 449

    CrossRef

  56. 56
    Per Ljungman , Prevention and treatment of viral infections in stem cell transplant recipients, British Journal of Haematology, 2002, 118, 1
  57. 57
    Trasplante de progenitores hematopoyéticos en pacientes y/o de donantes con infección por los virus de la hepatitis B o C: revisión y recomendaciones, Medicina Clínica, 2002, 118, 7, 268

    CrossRef

  58. 58
    Herbert L. Bonkovsky, Savant Mehta, Hepatitis C: A review and update, Journal of the American Academy of Dermatology, 2001, 44, 2, 159

    CrossRef

  59. 59
    Herbert L. Bonkovsky, Savant Mehta, Hepatitis C: A review and update, Disease-a-Month, 2001, 47, 12, 610

    CrossRef

  60. 60
    C. Liatsos, A. B. Mehta, M. Potter, A. K. Burroughs, The hepatologist in the haematologists' camp, British Journal of Haematology, 2001, 113, 3
  61. 61
    Stephanos J Hadziyannis, Dimitrios Vassilopoulos, Complex management issues: management of HCV in the atypical patient, Best Practice & Research Clinical Gastroenterology, 2000, 14, 2, 277

    CrossRef

  62. 62
    G.W. McCaughan, A. Zekry, Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection, Transplant Infectious Disease, 2000, 2, 4
  63. 63
    Steedman A. Sarbah, Zobair M. Younossi, Hepatitis C, Journal of Clinical Gastroenterology, 2000, 30, 2, 125

    CrossRef

  64. 64
    John P Galvin, Jayesh Mehta, Anti-Infective Prophylaxis, Immunization and Prevention of Recurrent Infectious Complications in Long-Term Survivors,
  65. 65
    Renée L Mulder, Elvira C van Dalen, Malon Van den Hof, Edith Leclercq, Dorine Bresters, Bart GP Koot, Sharon M Castellino, Yoon Loke, Piet N Post, Huib N Caron, Aleida Postma, Leontien CM Kremer, Hepatic late adverse effects after antineoplastic treatment for childhood cancer, The Cochrane Library,
  66. 66
    Josh Levitsky, Natasha Walzer, Hepatobiliary Complications of Hematopoietic Cell Transplantation,
  67. 67
    Keith Luckett, Stephen Dummer, Monitoring and Management of Hepatitis B, Hepatitis C, and HIV Infection before and after Transplantation,